<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="Agents0924-85791872-7913Published by Elsevier B.V. pmcid: 7135139S0924-8579(20)30082-0 doi: 10.1016/j.ijantimicag.2020.105932105932 : Article" exact="Chloroquine" post="and hydroxychloroquine as available weapons to fight COVID-19 ColsonPhilippeabRolainJean-MarcabLagierJean-ChristopheabBrouquiPhilippeabRaoultDidierdidier.raoult@gmail.comab⁎[a],"/>
 <result pre="Elsevier B.V. pmcid: 7135139S0924-8579(20)30082-0 doi: 10.1016/j.ijantimicag.2020.105932105932 : Article Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19 ColsonPhilippeabRolainJean-MarcabLagierJean-ChristopheabBrouquiPhilippeabRaoultDidierdidier.raoult@gmail.comab⁎[a], [b], ⁎Corresponding"/>
 <result pre="by virologists, as we experienced when reporting the effectiveness of" exact="azithromycin" post="for Zika virus [2]. A response has come from"/>
 <result pre="recent publication of results showing the in vitro activity of" exact="chloroquine" post="against SARS-CoV-2 [3], data have been reported on the"/>
 <result pre="obtained from more than 100 patients showed the superiority of" exact="chloroquine" post="compared with treatment of the control group in terms"/>
 <result pre="side effects [4,5]. This has led in China to include" exact="chloroquine" post="in the recommendations regarding the prevention and treatment of"/>
 <result pre="[4,6]. There is a strong rationality for the use of" exact="chloroquine" post="to treat infections with intracellular micro-organisms. Thus, malaria has"/>
 <result pre="with this molecule [7]. In addition, our team has used" exact="hydroxychloroquine" post="for the first time for intracellular bacterial infections since"/>
 <result pre="[8,9]. Since then, we have also shown the activity of" exact="hydroxychloroquine" post="on Tropheryma whipplei, the agent of Whipple's disease, which"/>
 <result pre="of Whipple's disease, which is another intracellular bacterium for which" exact="hydroxychloroquine" post="has become a reference drug [10,11]. Altogether, one of"/>
 <result pre="Regarding viruses, for reasons probably partly identical involving alkalinisation by" exact="chloroquine" post="of the phagolysosome, several studies have shown the effectiveness"/>
 <result pre="coronavirus [1,12,13] (Table 1 ). We previously emphasised interest in" exact="chloroquine" post="for the treatment of viral infections in this journal"/>
 <result pre="the discovery in China of the in vitro activity of" exact="chloroquine" post="against SARS-CoV-2, discovered during culture tests on Vero E6"/>
 <result pre="and also aroused great enthusiasm among us. They showed that" exact="chloroquine" post="could reduce the length of hospital stay and improve"/>
 <result pre="[4,6], leading to recommend the administration of 500 mg of" exact="chloroquine" post="twice a day in patients with mild, moderate and"/>
 <result pre="COVID-19 pneumonia. At such a dosage, a therapeutic concentration of" exact="chloroquine" post="might be reached. With our experience on 2000 dosages"/>
 <result pre="might be reached. With our experience on 2000 dosages of" exact="hydroxychloroquine" post="during the past 5 years in patients with long-term"/>
 <result pre="assessed in the coming days. For us, the activity of" exact="hydroxychloroquine" post="on viruses is probably the same as that of"/>
 <result pre="hydroxychloroquine on viruses is probably the same as that of" exact="chloroquine" post="since the mechanism of action of these two molecules"/>
 <result pre="Table 1 Main results of studies on the activity of" exact="chloroquine" post="or hydroxychloroquine on coronavirusesa Table 1 Reference Compound(s) Targeted"/>
 <result pre="Main results of studies on the activity of chloroquine or" exact="hydroxychloroquine" post="on coronavirusesa Table 1 Reference Compound(s) Targeted virus System"/>
 <result pre="virus System used for antiviral activity screening Antiviral effect [12]" exact="Chloroquine" post="SARS-CoV Vero (African green monkey kidney) E6 cells EC50"/>
 <result pre="kidney) E6 cells EC50 = 8.8 ± 1.2 μM [16]" exact="Chloroquine" post="Vero E6 cells EC50 = 4.4 ± 1.0 μM"/>
 <result pre="E6 cells EC50 = 4.4 ± 1.0 μM [17] Chloroquine," exact="chloroquine" post="monophosphate, chloroquine diphosphate SARS-CoV (four strains) Vero 76 cells"/>
 <result pre="EC50 = 4.4 ± 1.0 μM [17] Chloroquine, chloroquine monophosphate," exact="chloroquine" post="diphosphate SARS-CoV (four strains) Vero 76 cells Chloroquine: EC50"/>
 <result pre="diphosphate: EC50 = 3–4 μM BALB/c mice Intraperitoneal or intranasal" exact="chloroquine" post="administration, beginning 4 h prior to virus exposure: 50"/>
 <result pre="CCID50/g at Day 3 (considered as not significant) [18] Chloroquine," exact="hydroxychloroquine" post="SARS-CoV Vero cells Chloroquine: EC50 = 6.5 ± 3.2"/>
 <result pre="&amp;gt; 0.8 μMHydroxychloroquine: EC50 = 28 ± 27 μM [19]" exact="Chloroquine" post="HCoV-229E Human epithelial lung cells (L132) Chloroquine at concentrations"/>
 <result pre="27 μM [19] Chloroquine HCoV-229E Human epithelial lung cells (L132)" exact="Chloroquine" post="at concentrations of 10 μM and 25 μM inhibited"/>
 <result pre="25 μM inhibited HCoV-229E release into the culture supernatant [20]" exact="Chloroquine" post="HCoV-OC43 HRT-18 cells EC50 = 0.306 ± 0.0091 μM"/>
 <result pre="cells EC50 = 0.306 ± 0.0091 μM Newborn C57BL/6 mice;" exact="chloroquine" post="administration transplacentally and via maternal milk 100%, 93%, 33%"/>
 <result pre="15, 5, 1 and 0 mg/kg body weight, respectively [21]" exact="Chloroquine" post="Feline infectious peritonitis virus (FIPV) Felis catus whole fetus-4"/>
 <result pre="catus whole fetus-4 cells FIPV replication was inhibited in a" exact="chloroquine" post="concentration-dependent manner [22] Chloroquine SARS-CoV Vero E6 cells EC50"/>
 <result pre="FIPV replication was inhibited in a chloroquine concentration-dependent manner [22]" exact="Chloroquine" post="SARS-CoV Vero E6 cells EC50 = 4.1 ± 1.0"/>
 <result pre="liver cell line) EC50 = 3.3 ± 1.2 μM [3]" exact="Chloroquine" post="SARS-CoV-2 Vero E6 cells EC50 = 1.13 μM CCID50,"/>
 <result pre="[1] (Table 1) for additional references. References References 1RolainJ.M.ColsonP.RaoultD.Recycling of" exact="chloroquine" post="and its hydroxyl analogue to face bacterial, fungal and"/>
 <result pre="inhibits the replication of Zika virusJ Antivir Antiretrovir10201861110.4172/1948-5964.1000173 3WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="(2019-nCoV) in vitroCell Res2020 Feb 410.1038/s41422-020-0282-0[Epub ahead of print] 4GaoJ.TianZ.YangX.Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="of Guangdong Province and Health Commission of Guangdong Province for" exact="Chloroquine" post="in the Treatment of Novel Coronavirus PneumoniaExpert consensus on"/>
 <result pre="Chloroquine in the Treatment of Novel Coronavirus PneumoniaExpert consensus on" exact="chloroquine" post="phosphate for the treatment of novel coronavirus pneumonia [in"/>
 <result pre="from malaria to multifarious diseasesJ Antimicrob Chemother7020151608162110.1093/jac/dkv01825693996 8RaoultD.DrancourtM.VestrisG.Bactericidal effect of" exact="doxycycline" post="associated with lysosomotropic agents on Coxiella burnetii in P388D1"/>
 <result pre="DupontH.RissJ.M.Arditi-DjianeJ.BrouquiP.Treatment of Q fever endocarditis: comparison of 2 regimens containing" exact="doxycycline" post="and ofloxacin or hydroxychloroquineArch Intern Med159199916717310.1001/archinte.159.2.1679927100 10BoulosA.RolainJ.M.RaoultD.Antibiotic susceptibility of"/>
 <result pre="of p38 MAPK and ERKAntiviral Res77200815015210.1016/j.antiviral.2007.10.01118055026 20KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob Agents"/>
 <result pre="coronavirus OC43 infection in newborn miceAntimicrob Agents Chemother5320093416342110.1128/AAC.01509-0819506054 21TakanoT.KatohY.DokiT.HohdatsuT.Effect of" exact="chloroquine" post="on feline infectious peritonitis virus infection in vitro and"/>
</results>
